scispace - formally typeset
A

Amar Abderrahmani

Researcher at Imperial College London

Publications -  80
Citations -  3856

Amar Abderrahmani is an academic researcher from Imperial College London. The author has contributed to research in topics: Insulin & Apoptosis. The author has an hindex of 29, co-authored 69 publications receiving 3380 citations. Previous affiliations of Amar Abderrahmani include university of lille & University of Valenciennes and Hainaut-Cambresis.

Papers
More filters
Journal ArticleDOI

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion

TL;DR: It is demonstrated that SGLT2 is expressed in glucagon-secreting alpha cells of the pancreatic islets, and dapagliflozin treatment further promotes glucagon secretion and hepatic gluconeogenesis in healthy mice, thereby limiting the decrease of plasma glucose induced by fasting.
Journal ArticleDOI

MicroRNA-9 Controls the Expression of Granuphilin/Slp4 and the Secretory Response of Insulin-producing Cells

TL;DR: Evidence is provided that in insulin-producing cells adequate levels of mir-9 are mandatory for maintaining appropriate Granuphilin levels and optimal secretory capacity, and that silencing of Onecut-2 by RNA interference increases Gran Euphilin expression and mimics the effect of Mir-9 on stimulus-induced exocytosis.
Journal ArticleDOI

Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction

TL;DR: The findings suggest that at least part of the detrimental effects of palmitate on β-cells is caused by alterations in the level of specific miRNAs.
Journal ArticleDOI

Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β-cells

TL;DR: MiR-21, miR-34a, andmiR-146a are identified as novel players in β-cell failure elicited in vitro and in vivo by proinflammatory cytokines, notably during the development of peri-insulitis that precedes overt diabetes in NOD mice.
Journal ArticleDOI

MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.

TL;DR: Blockade of miR-338-3p in β cells using specific anti-miR molecules mimicked gene expression changes occurring during β cell mass expansion and resulted in increased proliferation and improved survival both in vitro and in vivo.